Page last updated: 2024-10-24

cetyltrimethylammonium ion and Carcinoma, Hepatocellular

cetyltrimethylammonium ion has been researched along with Carcinoma, Hepatocellular in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yue, CH1
Chen, CH1
Lee, WT1
Su, TF1
Pan, YR1
Chen, YP1
Huang, FM1
Lee, CJ1

Other Studies

1 other study available for cetyltrimethylammonium ion and Carcinoma, Hepatocellular

ArticleYear
Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells
    Anticancer research, 2020, Volume: 40, Issue:8

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Cetrimonium; Dose-Respons

2020